Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2–1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety of histologic subtypes associated with different clinical outcomes. Due to its rarity in children, TETs’ management requires a multidisciplinary approach. However, prognosis remains still poor, especially among patients with thymic carcinoma. This study presents the internationally recognized recommendations for the diagnosis and treatment of thymic tumors in children and adolescents, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) group within the EU‐funded project Paediatric Rare Tumours Network ‐ European Registry (PARTNER).

[1]  Y. Hosomi,et al.  Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study. , 2019, European journal of cancer.

[2]  V. Torri,et al.  RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma , 2018, Clinical lung cancer.

[3]  E. Ruffini,et al.  Optimal surgical approach to thymic malignancies: New trends challenging old dogmas. , 2018, Lung cancer.

[4]  G. Giaccone,et al.  Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. , 2018, The Lancet. Oncology.

[5]  W. Fang,et al.  Minimally invasive surgery in thymic malignances: the new standard of care. , 2018, Journal of thoracic disease.

[6]  J. Shrager,et al.  Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  R. Giovannetti,et al.  VATS thymectomy for early stage thymoma and myasthenia gravis: combined right-sided uniportal and left-sided three-portal approach. , 2017, Journal of visualized surgery.

[8]  F. Detterbeck,et al.  Comparison of surgical approach and extent of resection for Masaoka-Koga Stage I and II thymic tumours in Europe, North America and Asia: an International Thymic Malignancy Interest Group retrospective database analysis† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  R. Toyozawa,et al.  Are Anthracycline‐Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma? , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  A. Ferrari,et al.  Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). , 2015, European journal of cancer.

[11]  N. Girard,et al.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  N. Girard,et al.  Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  P. Meltzer,et al.  Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. , 2015, The Lancet. Oncology.

[14]  A. Nicholson,et al.  The Impact of Thymoma Histotype on Prognosis in a Worldwide Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  F. Varlet,et al.  Surgical management of thymic epithelial tumors in children: Lessons from the French Society of pediatric oncology and review of the literature , 2014, Pediatric blood & cancer.

[16]  J. Crowley,et al.  The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  E. Lancaster,et al.  Paraneoplastic Disorders in Thymoma Patients , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  N. Altorki,et al.  Thymic Carcinoma: A Cohort Study of Patients from the European Society of Thoracic Surgeons Database , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  G. Giaccone,et al.  Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. , 2014, The Lancet. Oncology.

[20]  James S. Davis,et al.  An analysis of 73 cases of pediatric malignant tumors of the thymus. , 2013, The Journal of surgical research.

[21]  N. Girard,et al.  Thymic tumours: an update. , 2013, Presse medicale.

[22]  A. Tangoku,et al.  18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  R. Munden,et al.  FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  M. Onizuka,et al.  Early-stage thymic carcinoma: is adjuvant therapy required? , 2013, Journal of thoracic disease.

[25]  W. Cheung,et al.  Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  A. Bezjak,et al.  The Management of Thymoma: A Systematic Review and Practice Guideline , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  A. Fattorossi,et al.  Paraneoplastic diseases associated with thymoma , 2007, Journal of Neurology.

[28]  N. Müller,et al.  Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. , 2006, European journal of radiology.

[29]  H. Müller-Hermelink,et al.  Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Y. Tseng,et al.  Thymic carcinoma: involvement of great vessels indicates poor prognosis. , 2003, The Annals of thoracic surgery.

[31]  K. Kondo,et al.  Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. , 2003, The Annals of thoracic surgery.

[32]  H. Matsuda,et al.  The World Health Organization histologic classification system reflects the oncologic behavior of thymoma , 2002, Cancer.

[33]  C. Dykewicz.  Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  K. S. Lee,et al.  Malignant thymic epithelial tumors: CT-pathologic correlation. , 2001, AJR. American journal of roentgenology.

[35]  G. Giaccone,et al.  Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  G. Altavilla,et al.  Chemotherapy and operation for invasive thymoma. , 1993, The Journal of thoracic and cardiovascular surgery.

[37]  S. Sone,et al.  MR imaging of thymoma: radiologic-pathologic correlation. , 1992, AJR. American journal of roentgenology.

[38]  A. Paccagnella,et al.  Chemotherapy of invasive thymoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  David R. Jones,et al.  Thymic carcinoma outcomes and prognosis: results of an international analysis. , 2015, The Journal of thoracic and cardiovascular surgery.

[40]  A. Nicholson,et al.  [The Masaoka-Koga stage classification for thymic malignancies clarification and definition of terms]. , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.